Zobrazeno 1 - 10
of 23
pro vyhledávání: '"David Okrongly"'
Autor:
Yan Dong, Ana Calatrava, Ángel Borque-Fernando, Bernardo Herrera-Imbroda, Luis M. Esteban, Jorge García-Rodríguez, Pedro A. González, Juan Soto-Villalba, Sara Martínez-Breijo, Virginia Hernández-Cañas, Nuria Rodríguez-García, Miguel Rodrigo-Aliaga, Enrique Gómez-Gómez, David Okrongly, Yumaira E. Hernández-Martínez, Carlos Carrillo-George, Carlos Sánchez-Rodríguez, Jesús M Gil Fabra, Ana M. Soto-Poveda, José Rubio-Briones, Álvaro Gómez-Ferrer
Publikováno v:
PROSTATE CANCER AND PROSTATIC DISEASES
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Management of active surveillance (AS) in low-risk prostate cancer (PCa) patients could be improved with new biomarkers, such as the 4Kscore test. We analyze its ability to predict tumor reclassification by upgrading at the confirmatory biopsy at 6 m
Publikováno v:
American Journal of Clinical Pathology. 146
Publikováno v:
Journal of Urology. 195
Autor:
Yan Dong, Mitchell S. Steiner, Richard G. Roberts, Dan Sjoberg, David Okrongly, Vincent Linder, Jay Newmark, Michael Reeve, Vinita Mathur, Grannum R. Sant
Publikováno v:
Journal of Urology. 193
INTRODUCTION AND OBJECTIVES: Numerous studies have reported a significantly higher incidence of PCa and/or adverse pathological features associated with African-American men compared to European-American men. Less however is known about the genomic d
Autor:
Marion G. Macey, David Okrongly, David Zelmanovic, Adrian C. Newland, Urooj Azam, Desmond A. McCarthy, Lee Webb, E. Sabrinah Chapman
Publikováno v:
Clinical Chemistry. 48:891-899
Background: Monitoring of platelet activation by the ADVIA® 120 Hematology System requires an anticoagulant and protocol that ensures that platelets are sphered and their activation status is not altered artifactually in vitro. Methods: Blood from h
Autor:
Stephen M. Zappala, Yan Dong, Vincent Linder, Michael Reeve, Daniel D. Sjoberg, Vinita Mathur, Richard Roberts, David Okrongly, Jay Newmark, Garnnum Sant, Mitchell Steiner
Publikováno v:
International Journal of Clinical Practice. 71:e12983
Autor:
Stephen M. Zappala, David Okrongly, Michael Reeve, Vinita Mathur, Vincent Linder, Jay Newmark, Richard Roberts, Garnnum Sant, Yan Dong, Mitchell Steiner, Daniel Sjöberg
Publikováno v:
International Journal of Clinical Practice. 71:e12943
SummaryIntroduction The 4Kscore Test is a prebiopsy blood test that incorporates four prostate protein biomarkers along with patient clinical information to determine a man's risk for high-grade, aggressive (Gleason ≥7) prostate cancer. However, so
Autor:
Neal D. Shore, James S. Cochran, Daniel Saltzstein, Vipul Patel, Gordon D. Brown, James M. McKiernan, Michael J. Donovan, Ketan K. Badani, Mikkel Noerholm, Susan Belzer, David Okrongly, Jennifer Ahn, Stefan Bentink, Leileata M. Russo, Raoul S. Concepcion, Wayne D. Comper, Edan Y. Shapiro
Publikováno v:
Journal of Urology. 189
Publikováno v:
Journal of Hematotherapy. 3:37-46
The plant lectin, soybean agglutinin (SBA), has been widely used to separate heterogeneous populations of cells. In the field of bone marrow transplantation, SBA has been used for partial depletion of T cells from bone marrow allografts to reduce gra
Autor:
Flemming W. Bach, Fuad Fares, Rodrigo Kuljis, Benito Regueiro, Kunïkazu Kondo, Moshe Gavish, Paul M. Dubois, Iván Nagy, Harry Brandt, Andreas Kjaer, Alessandro D. Genazzani, Zsuzsanna Ács, Kjell Fuxe, Guido Ficarra, Samuel M. McCann, Emanuel Meller, Michael D. DeBellis, B Bidzinska, Shalom Bar-Ami, Andrea Gallinelli, Valeria Sibilia, Kazuo Otake, Philip W. Gold, Jørgen Warberg, Konstantine T. Kalogeras, Stefano Angioni, Donna L. Tempel, Ulrich Knigge, Antonio Pecile, F. V. Vega, Rodrigo O. Kuljis, Antonio Cintra, Ulrich Renner, Gian Paolo Trentini, Christoph J. Auernhammer, Dipak K. Sarkar, Jamshid Rabii, Juan-Pablo Advis, Koki Fukuhara, Bruce S. McEwen, Luís Lima, Mark A. Demitrack, Nicholas C. Vamvakopoulos, Clara V. Alvarez, Francesca Guidobono, Esperanza Cancio, Karen Bohmaker, Felice Petraglia, Charles D. Conover, M. Criscuolo, Michaela Diamant, V. Solfrini, Takashi Murase, Rabia Bouali-Benazzouz, Maryse Bonnin, Bernd Bunnemann, Jason Diamond, A. G. Reznikov, Jan-Ake Gustafsson, Kent E. Vrana, Zsuzsanna Mergl, Jesús Devesa, Aziz El Amraoui, Víctor M. Arce, Abraham Weizman, Harvey J. Whitfield, Vladimir K. Patchev, Sarah F. Leibowitz, Marie-Claude Audy, Mitchel A. Kling, Günter K. Stalla, Johanna Stalla, Sam Okret, Shanaz M. Tejani-Butt, Jesús A.F. Tresguerres, Lawrence A. Frohman, Zamir Amiri, Stephen J. Walker, Francesca Bortolotti, Charles Conover, Samuel J. Listwak, Yutaka Oiso, Carmela Netti, David de Wied, Jianxin Yang, Balakrishna M. Prasad, Béla Halász, Tracy Puza, George P. Chrousos, Michael Schütte, David Okrongly, Amir Kaviani, Gábor B. Makara, Fernando Domínguez, Juan Zalvide, Menek Goldstein, Gyula Horvath, Joh Y. Lew, Andrea R. Genazzani, O. A. Müller, Makoto Sato, Carlos Dieguez
Publikováno v:
Neuroendocrinology. 57:1211-1214